Wolverine Trading, LLC Citius Pharmaceuticals, Inc. Call Options Transaction History

Wolverine Trading, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 15, 2023	SELL	$0.65 - $1.25 $2,405 - $4,625	-3,700 Reduced 15.95%	19,500 $13,000
Q2 2023 Aug 23, 2023	BUY	$1.08 - $1.65 $6,588 - $10,065	6,100 Added 35.67%	23,200 $27,000
Q1 2023 May 15, 2023	SELL	$0.78 - $1.42 $13,182 - $23,998	-16,900 Reduced 49.71%	17,100 $20,000
Q4 2022 Feb 14, 2023	BUY	$0.79 - $1.28 $3,871 - $6,272	4,900 Added 16.84%	34,000 $27,000
Q3 2022 Nov 14, 2022	BUY	$0.14 - $1.33 $4,074 - $38,703	29,100 New	29,100 $37,000
Q2 2022 Aug 15, 2022	SELL	$0.88 - $1.87 $15,136 - $32,164	-17,200 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.38 - $1.89 $23,735 - $32,508	17,200 New	17,200 $30,000

23.7M

83.1K

32.1K

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $457M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.